BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 34244972)

  • 1. The impact of mitochondria on cancer treatment resistance.
    van der Merwe M; van Niekerk G; Fourie C; du Plessis M; Engelbrecht AM
    Cell Oncol (Dordr); 2021 Oct; 44(5):983-995. PubMed ID: 34244972
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mitochondrial dysfunctions in cancer: genetic defects and oncogenic signaling impinging on TCA cycle activity.
    Desideri E; Vegliante R; Ciriolo MR
    Cancer Lett; 2015 Jan; 356(2 Pt A):217-23. PubMed ID: 24614286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An Overview: The Diversified Role of Mitochondria in Cancer Metabolism.
    Liu Y; Sun Y; Guo Y; Shi X; Chen X; Feng W; Wu LL; Zhang J; Yu S; Wang Y; Shi Y
    Int J Biol Sci; 2023; 19(3):897-915. PubMed ID: 36778129
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mitochondria and cancer chemoresistance.
    Guerra F; Arbini AA; Moro L
    Biochim Biophys Acta Bioenerg; 2017 Aug; 1858(8):686-699. PubMed ID: 28161329
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic alterations in Krebs cycle and its impact on cancer pathogenesis.
    Sajnani K; Islam F; Smith RA; Gopalan V; Lam AK
    Biochimie; 2017 Apr; 135():164-172. PubMed ID: 28219702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitochondrial metabolism as a dynamic regulatory hub to malignant transformation and anti-cancer drug resistance.
    Tomar MS; Kumar A; Shrivastava A
    Biochem Biophys Res Commun; 2024 Jan; 694():149382. PubMed ID: 38128382
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of Nrf2 and mitochondria in cancer stem cells; in carcinogenesis, tumor progression, and chemoresistance.
    Payandeh Z; Pirpour Tazehkand A; Barati G; Pouremamali F; Kahroba H; Baradaran B; Samadi N
    Biochimie; 2020 Dec; 179():32-45. PubMed ID: 32946993
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting Mitochondrial Oncometabolites: A New Approach to Overcome Drug Resistance in Cancer.
    Godel M; Ortone G; Anobile DP; Pasino M; Randazzo G; Riganti C; Kopecka J
    Pharmaceutics; 2021 May; 13(5):. PubMed ID: 34065551
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isocitrate dehydrogenase (IDH), succinate dehydrogenase (SDH), fumarate hydratase (FH): three players for one phenotype in cancer?
    Laurenti G; Tennant DA
    Biochem Soc Trans; 2016 Aug; 44(4):1111-6. PubMed ID: 27528759
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The connection between tricarboxylic acid cycle enzyme mutations and pseudohypoxic signaling in pheochromocytoma and paraganglioma.
    Wang Y; Liu B; Li F; Zhang Y; Gao X; Wang Y; Zhou H
    Front Endocrinol (Lausanne); 2023; 14():1274239. PubMed ID: 37867526
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current and upcoming mitochondrial targets for cancer therapy.
    Kim HK; Noh YH; Nilius B; Ko KS; Rhee BD; Kim N; Han J
    Semin Cancer Biol; 2017 Dec; 47():154-167. PubMed ID: 28627410
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mitochondria and Cancer.
    Zong WX; Rabinowitz JD; White E
    Mol Cell; 2016 Mar; 61(5):667-676. PubMed ID: 26942671
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Revisiting the TCA cycle: signaling to tumor formation.
    Raimundo N; Baysal BE; Shadel GS
    Trends Mol Med; 2011 Nov; 17(11):641-9. PubMed ID: 21764377
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting the Mitochondrial Metabolic Network: A Promising Strategy in Cancer Treatment.
    Frattaruolo L; Brindisi M; Curcio R; Marra F; Dolce V; Cappello AR
    Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32825551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer cell metabolism: Rewiring the mitochondrial hub.
    Oliveira GL; Coelho AR; Marques R; Oliveira PJ
    Biochim Biophys Acta Mol Basis Dis; 2021 Feb; 1867(2):166016. PubMed ID: 33246010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oncometabolites: Unconventional triggers of oncogenic signalling cascades.
    Sciacovelli M; Frezza C
    Free Radic Biol Med; 2016 Nov; 100():175-181. PubMed ID: 27117029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting Mitochondrial OXPHOS and Their Regulatory Signals in Prostate Cancers.
    Chen CL; Lin CY; Kung HJ
    Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948229
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic changes associated with tumor metastasis, part 2: Mitochondria, lipid and amino acid metabolism.
    Porporato PE; Payen VL; Baselet B; Sonveaux P
    Cell Mol Life Sci; 2016 Apr; 73(7):1349-63. PubMed ID: 26646069
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mitochondrial Transfer in Cancer: A Comprehensive Review.
    Zampieri LX; Silva-Almeida C; Rondeau JD; Sonveaux P
    Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33806730
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insights into new mechanisms and models of cancer stem cell multidrug resistance.
    Garcia-Mayea Y; Mir C; Masson F; Paciucci R; LLeonart ME
    Semin Cancer Biol; 2020 Feb; 60():166-180. PubMed ID: 31369817
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.